# Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis

> **NCT00803738** · NA · COMPLETED · sponsor: **Padagis LLC** · enrollment: 572 (actual)

## Conditions studied

- Vulvovaginal Candidiasis

## Interventions

- **DRUG:** Terconazole Vaginal Suppository
- **DRUG:** Terazol Vaginal Suppository

## Key facts

- **NCT ID:** NCT00803738
- **Lead sponsor:** Padagis LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** 572 (ACTUAL)
- **Last updated:** 2021-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00803738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00803738, "Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00803738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*